These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20956618)

  • 1. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.
    Kao SC; Pavlakis N; Harvie R; Vardy JL; Boyer MJ; van Zandwijk N; Clarke SJ
    Clin Cancer Res; 2010 Dec; 16(23):5805-13. PubMed ID: 20956618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.
    Woolhouse I; Bishop L; Darlison L; De Fonseka D; Edey A; Edwards J; Faivre-Finn C; Fennell DA; Holmes S; Kerr KM; Nakas A; Peel T; Rahman NM; Slade M; Steele J; Tsim S; Maskell NA
    Thorax; 2018 Mar; 73(Suppl 1):i1-i30. PubMed ID: 29444986
    [No Abstract]   [Full Text] [Related]  

  • 3. Unexpected longevity of a patient with malignant pleural mesothelioma: report of a case.
    Fischbein A; Suzuki Y; Selikoff IJ; Bekesi JG
    Cancer; 1978 Oct; 42(4):1999-2004. PubMed ID: 309354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTS statement on malignant mesothelioma in the UK, 2007.
    British Thoracic Society Standards of Care Committee
    Thorax; 2007 Nov; 62 Suppl 2(Suppl 2):ii1-ii19. PubMed ID: 17965072
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent advances in mesothelioma.
    Dark G
    Clin Med (Lond); 2003; 3(4):314-7. PubMed ID: 12938743
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply: comment on 'Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'.
    Szkandera J; Pichler M; Gerger A; Leithner A
    Br J Cancer; 2013 Jun; 108(12):2627. PubMed ID: 23736030
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.
    Curran D; Sahmoud T; Therasse P; van Meerbeeck J; Postmus PE; Giaccone G
    J Clin Oncol; 1998 Jan; 16(1):145-52. PubMed ID: 9440736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.
    Herndon JE; Green MR; Chahinian AP; Corson JM; Suzuki Y; Vogelzang NJ
    Chest; 1998 Mar; 113(3):723-31. PubMed ID: 9515850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.
    Chua W; Charles KA; Baracos VE; Clarke SJ
    Br J Cancer; 2011 Apr; 104(8):1288-95. PubMed ID: 21448173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis.
    Chen N; Liu S; Huang L; Li W; Yang W; Cong T; Ding L; Qiu M
    Oncotarget; 2017 Aug; 8(34):57460-57469. PubMed ID: 28915685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-based prognostic indices in malignant pleural mesothelioma.
    Pinato DJ; Mauri FA; Ramakrishnan R; Wahab L; Lloyd T; Sharma R
    J Thorac Oncol; 2012 Mar; 7(3):587-94. PubMed ID: 22307011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Inflammation-related Biomarkers on Overall Survival of Patients with Inoperable Malignant Pleural Mesothelioma.
    Otoshi T; Kataoka Y; Kaku S; Iki R; Hirabayashi M
    In Vivo; 2018; 32(2):445-450. PubMed ID: 29475935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in Good Performance Malignant Pleural Mesothelioma Patients; Prognostic Factors and Predictors of Response.
    Rahouma M; Aziz H; Ghaly G; Kamel M; Loai I; Mohamed A
    Asian Pac J Cancer Prev; 2017 Aug; 18(8):2073-2078. PubMed ID: 28843224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?
    Tural Onur S; Sokucu SN; Dalar L; Iliaz S; Kara K; Buyukkale S; Altin S
    Ther Clin Risk Manag; 2016; 12():651-6. PubMed ID: 27217757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.
    Yamagishi T; Fujimoto N; Nishi H; Miyamoto Y; Hara N; Asano M; Fuchimoto Y; Wada S; Kitamura K; Ozaki S; Kishimoto T
    Lung Cancer; 2015 Oct; 90(1):111-7. PubMed ID: 26259877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.
    Hu B; Yang XR; Xu Y; Sun YF; Sun C; Guo W; Zhang X; Wang WM; Qiu SJ; Zhou J; Fan J
    Clin Cancer Res; 2014 Dec; 20(23):6212-22. PubMed ID: 25271081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NETosis: nature's alarm system in cancer progression.
    Liang Y; Wu G; Tan J; Xiao X; Yang L; Saw PE
    Cancer Drug Resist; 2024; 7():28. PubMed ID: 39143953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating LENT score in malignant pleural effusion.
    Alawneh A; Farsakh FA; Smadi M; Samrah S
    Future Sci OA; 2024; 10(1):FSO958. PubMed ID: 38817378
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab.
    Suzuki S; Taguchi Y; Kitabayashi T; Sato N; Kaya H; Abe T; Endo T; Suzuki H; Kawasaki Y; Yamada T
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38730986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.